By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...
Investor's Business Daily on MSN
Eli Lilly's pill lags Novo Nordisk's in first week. Why stock rallied.
Eli Lilly's oral weight-loss drug, Foundayo, nabbed 1,390 prescriptions in its first week on the market, analysts said Friday.
At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...
Lilly plans to file Foundayo with the FDA for type 2 diabetes by end of Q2 after the ACHIEVE-4 trial met its primary ...
The FDA is asking Eli Lilly to submit cardiovascular and liver safety data from an ongoing Phase 3 trial of Foundayo by July.
The pill is the most common way Australian women avoid getting pregnant. Almost 30% of Australian women who use contraception ...
Eli Lilly has announced the availability of the new GLP-1 pill, Foundayo, through Amazon One Medical kiosks starting at $149 ...
By Sriparna Roy April 14 (Reuters) - The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury ...
The FDA also asked Lilly to conduct a milk-only lactation study in women who have received a dose to assess concentrations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results